On October 28th, Huapont Life Sciences (002004.SZ) announced its third quarter report for 2024, with the company achieving revenue of 8.9098 billion yuan in the first three quarters, a year-on-year increase of 0.64%; the net income attributable to shareholders of the listed company was 0.452 billion yuan, a year-on-year decrease of 10.49%; the net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 0.436 billion yuan, a year-on-year decrease of 9.78%; and the basic earnings per share was 0.2288 yuan.
华邦健康(002004.SZ)：前三季度净利润4.52亿元 同比下降10.49%
huapont life sciences (002004.SZ): net income of 0.452 billion yuan in the first three quarters, a year-on-year decrease of 10.49%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha